Skip to the content
  • Our Company
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science & Innovation
    • Our Approach
    • Our Pipeline
  • Culture
  • Media
    • Resources
    • News
  • News
  • Contact
  • Our Company
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science & Innovation
    • Our Approach
    • Our Pipeline
  • Culture
  • Media
    • Resources
    • News
  • News
  • Contact

Lighting the Way to Breakthrough Medicines

Delivering on the Promise of Oral Peptides

At Nimble, we're pioneering the development of oral therapies for immune-mediated diseases that mirror the effects of well-established treatments. By harnessing the power of our proven discovery engine, we're accelerating the advancement of our emerging pipeline into clinical trials.

Our Approach
Our Pipeline

PRE-HEADER

Lorem Ipsum Dolor 
Sit Amet Consectetur Adipiscing

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus sollicitudin purus non ex finibus tincidunt. Pellentesque blandit sapien sed urna convallis vehicula.
Call to Action

PIPELINE WITH PROMISE

Our Platform Accelerates The Discovery Of Oral Therapies

See Our Pipeline

Recent News

Press Release

AbbVie Completes Acquisition of Nimble Therapeutics

Read Press Release
Press Release

AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline

Read Press Release

More To Read

Press Release
  • January 23, 2025

AbbVie Completes Acquisition of Nimble Therapeutics

Read Press Release
Press Release
  • December 13, 2024

AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology Pipeline

Read Press Release
Press Release
  • June 11, 2024

Nimble Announces Formation of a World-Class Scientific Advisory Board

Read Press Release
View All News
  • Our Team
  • Our Pipeline
  • Partner
  • Resources
  • News
  • Careers
  • Contact
  • Our Team
  • Our Pipeline
  • Partner
  • Resources
  • News
  • Careers
  • Contact
  • CONNECT ON LINKEDIN

Copyright © 2024 Nimble Therapeutics, Inc

Nimble Therapeutics is now AbbVie

Read the announcement